[ Back to EurekAlert! ]

Contact: Russell Grant
grantr@fleishman.com
212-453-2430
Fleishman-Hillard

B-roll Support and Animation

Loading video...

Caption: These are the Newsfeed Contents: B-roll: Animation of Neoadjuvant Treatment / Animation of How Perjeta is Thought to Work / Perjeta Manufacturing, Lab and Product / Genentech Corporate Campus

Credit: B-roll provided by Genentech.

Usage Restrictions: None

Related news release: FDA grants Genentech's Perjeta® (pertuzumab) accelerated approval for use before surgery in people with HER2-positive early stage breast cancer


[ Back to EurekAlert! ]